Physician profile
Sugene Kim
NPI 1386841468
$8,696.44
in general payments reported to CMS, 2019-2025
9 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what 79% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $789 · 2020: $558 · 2021: $622 · 2022: $1,253 · 2023: $811 · 2024: $3,266 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,409 · Travel and Lodging: $1,500 · Consulting Fee: $1,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,408.66 |
| Travel and Lodging | $1,500.00 |
| Consulting Fee | $1,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $565.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $3,218.18 | 2024-2025 | |
| Allergan, INC. | $2,551.65 | 2019-2023 | |
| Abbvie INC. | $1,637.14 | 2023-2025 | |
| Merz North America, INC. | $561.81 | 2019-2020 | |
| Revance Therapeutics, INC. | $258.61 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $251.46 | 2022-2025 | Dysport |
| Sientra, INC. | $102.20 | 2020 | |
| Mentor Worldwide LLC | $64.20 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Pacira Pharmaceuticals Incorporated | $51.19 | 2024-2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sugene Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.